A Method for Detecting Five Carbapenemases in Bacteria Based on CRISPR-Cas12a Multiple RPA Rapid Detection Technology
DOI: https://doi.org/10.2147/idr.s429707
2024-04-25
Infection and Drug Resistance
Abstract:Huaming Xu, 1 Chunhui Lin, 2, 3 Hao Tang, 4 Rongrong Li, 2, 3 Zhaoxin Xia, 2, 3 Yi Zhu, 3 Zhen Liu, 2, 3 Jilu Shen 2, 3 1 The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, People's Republic of China; 2 The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China; 3 Anhui Public Health Clinical Center, Hefei, People's Republic of China; 4 The Second Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China Correspondence: Jilu Shen, Tel +86 151 5515 2963, Email ; Introduction: As the last line of defense for clinical treatment, Carbapenem antibiotics are increasingly challenged by multi-drug resistant bacteria containing carbapenemases. The rapid spread of these multidrug-resistant bacteria is the greatest threat to severe global health problems. Methods: To solve the problem of rapid transmission of this multidrug-resistant bacteria, we have developed a rapid detection technology using CRPSPR-Cas12a gene editing based on multiple Recombinase polymerase amplification. This technical method can directly isolate the genes of carbapenemase-containing bacteria from samples, with a relatively short detection time of 30 minutes. The instrument used for the detection is relatively inexpensive. Only a water bath can complete the entire experiment of Recombinase polymerase amplification and trans cleavage. This reaction requires no lid during the entire process while reducing a large amount of aerosol pollution. Results: The detection sensitivity of this method is 1.5 CFU/mL, and the specificity is 100%. Discussion: This multi-scene detection method is suitable for screening populations in wild low-resource environments and large-scale indoor crowds. It can be widely used in hospital infection control and prevention and to provide theoretical insights for clinical diagnosis and treatment. In recent years, multidrug-resistant bacteria containing carbapenemase have spread rapidly worldwide. The high incidence and mortality rates of these bacteria, the limited drugs used to treat such bacteria, the prolonged hospitalization, and the high cost of hospitalization pose a severe threat to patients' health. 1 Carbapenems antibiotics are potent in fighting Pseudomonas aeruginosa and multidrug-resistant Gram-negative bacilli infections and play an essential role in clinical anti-infection treatment. Due to its broad anti-bacterial spectrum and strong and stable anti-bacterial effect, 2 β–lactamases are commonly used in treating severe infections caused by multidrug-resistant strains. Therefore, these antibiotics are widely used in clinical anti-infection treatments. Under antibiotic selection pressure, clinical isolates with carbapenemase-coding genes, but no phenotypic expression, can quickly transform into carbapenemase-expressing bacteria through gene replication, resulting in drug-resistant strains, limited clinical treatment options, and poor therapeutic effectiveness. 3 Currently, the laboratory detection methods for Enterobacteriaceae containing carbapenemase are mainly divided into phenotypic, genotypic, and other detection methods. Phenotypic detection methods mainly include the Hodge experiment, Carba NP experiment, mCIM and eCIM experiment, micro broth dilution experiment, and macro broth dilution experiment. Genotype detection methods include real-time molecular Xpert Carba-R detection, PCR, multiplex PCR, nested PCR, RT-PCR combined with microfluidic technology, and isothermal amplification technology. 4 Molecular detection has the characteristics of fast, accurate, high sensitivity, strong stability, and high specificity. It can accurately identify five different carbapenemases, which help clinical workers choose anti-bacterial drugs while avoiding adverse reactions caused by drug abuse. 5 Clinicians can scientifically formulate treatment plans and guide clinical medication based on genetic testing results. In addition, other new carbapenemases detection technologies include MALDI-TOF MS, selective and color development culture, enzyme immunochromatography, and identification of carbapenemases from volatile metabolites. 6 With the rapid development of molecular detection technology, the diagnosis method based on nucleic acid detection has been widely used in the laboratory detection of human diseases. Recombinant enzyme polymerase amplification (RPA) is a new isothermal amplification technique. Similar to the traditional PCR 7 method, the principle of this method is to design positive and negative primers for specific g -Abstract Truncated-
pharmacology & pharmacy,infectious diseases